Takeaway
In patients that developed remote intracerebral hemorrhage (r-ICH) after receiving intravenous recombinant tissue plasminogen activator (IV rtPA), nearly half of them had preexisting brain lesions, all of which were of vascular origin.
Why this matters
Understanding the relationship between IV rtPA and r-ICH will aid in clinical decision-making.